Senior Director, National Accounts and Field Reimbursement

Position Summary:

We are seeking a Senior Director, National Accounts and Field Reimbursement who will report to the Vice President, Market Access. You will be responsible for developing and executing the strategic payer plan to secure appropriate market access for Gedatolisib, Celcuity’s first commercialized product in late-stage Breast Cancer. Additionally, this individual will be responsible for field reimbursement support following approval.

As a member of the Market Access leadership team, this person is responsible for the development and execution of strategies with National Payers, Selected Regional Payers, Payer Pathways, state Medicaid, and Medicare MACs ensuring formulary and pathway access of Celcuity’s product(s) for appropriate patients.

Responsibilities:

• Customer facing roles responsible for the development and execution of access strategies with all target payer accounts.
• Leading, managing, and developing a field team of National Account Directors.
• Responsible for development of cross-functional account plans and overall customer relationship management.
• Organize and oversee target customer executive exchange meetings by mobilizing teams across Market Access, Medical Affairs and the Executive Leadership Team.
• Provide strategic inputs and customer insights to shape the launch strategies and the development of payer and reimbursement materials.
• Partner with Sales Leadership to equip sales with clear, compliant payer and reimbursement messaging.
• Ensure consistent collaboration and coordination with sales on field reimbursement initiatives to minimize access barriers and support providers in a efficient and timely manner.
• Establish a closed-loop partnership with the sales team to capture/share real-time field insights and access/payer formulary wins and .
• Lead payer related account activities with cross-functional teams and key internal stakeholders to ensure Access strategies are implemented and tracking to established timelines, objectives and goals.
• Lead field reimbursement support for field-based teams’ post-approval.
• Responsible for communicating reimbursement landscape to senior leadership; including economic understandings.
• Other duties as assigned.

Qualifications:

• B.S. degree or related industry experience.
• Ten plus (10+) years of pharmaceutical experience
• Deep understanding of Payer trends and established executive relationships with National/Regional and Commercial/Government plans.
• Minimum of 2+ years of People management
• Minimum of 5 years of Oncology experience
• Oral and IV experience
• Demonstrated teamwork and leadership including the ability to influence without positional authority
• Effective and agile decision making and problem-solving skills
• Excellent analytical skills and ability to effectively utilize available market data to understand all aspects of the market access channel landscape
• Superior written, oral, and group communication skills
• Must understand US pharmaceutical operations, healthcare and reimbursement landscape
• Proven success in developing executive level approval of contract business cases including the rigorous financial analytics

Preferred:

• Oncology Sales Experience is a plus but not required
• Experience with emerging commercial company
• Master’s degree or advanced degree preferred

About Us:

Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.

Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going.

Celcuity is an Equal-Opportunity Employer.

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $277,000 - $310,000. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.

Notice to Recruiters/Staffing Agencies

Recruiters and staffing agencies should not contact Celcuity through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization and will be considered unsolicited. Celcuity will not be responsible for related fees.